Outliyr’s Independent Spectrometer Tests Find Popular Red Light Therapy Devices Delivering From 67 Percent to Nearly Triple Their Advertised Power

In this episode of Global Economic Press, Alex Brady delves into the intriguing findings from Outliyr's independent spectrometer tests on red light therapy devices. These tests have uncovered significant discrepancies between the advertised and actual power outputs of these devices, with some delivering as little as 67 percent and others nearly triple their advertised power. This revelation raises important questions about transparency and consumer trust within the industry. Alex discusses the implications of these findings for both consumers and manufacturers, emphasizing the need for reliable data to guide purchasing decisions in a market where buyers often spend substantial amounts based on advertised figures. Outliyr has established a comprehensive database cataloging over seventy light therapy devices, providing independent spectrometer measurements for the units tested. This database allows consumers to compare devices based on measured data rather than marketing claims, offering a more transparent view of the products' performance. Nick Urban, founder of Outliyr, highlights the importance of providing consumers with verified measurements before they make significant financial commitments. The database and testing methodology are publicly accessible, ensuring that consumers and reporters can explore the data freely. For more information, visit Outliyr's website at Outliyr.